Ana Paula Marchi

Ana Paula Marchi

Auto-generated profile, based on publicly available information

Ana Paula Marchi

Universidade de São Paulo, Brazil; Universidade de São Paulo, Brazil

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 October 2018 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Closed access
LNLauro Vieira Perdigão Neto
Lauro Vieira Perdigão Neto
MOMaura S Oliveira
Maura S Oliveira
RMRoberta Cristina Ruedas Martins
Roberta Cristina Ruedas Martins
AMAna Paula Marchi
Ana Paula Marchi
JGJuliana Januário Gaudereto
Juliana Januário Gaudereto
ALAnna S Levin
Anna S Levin
In vitro and clinical studies using parenteral fosfomycin have suggested the possibility of using this drug against infections caused by MDR microorganisms. The aim of this study was to describe a case series of patients treated with fosfomycin who had severe infections caused by pan-drug-resistant Gram-negative bacteria. We describe a prospective series of cases of hospitalized patients with infections caused by Gram-negative bacteria resistant to β-lactams and colistin, treated with 16 g of fosfomycin daily for 10-14 days. Isolates were tested for antimicrobial susceptibility and synergism of fosfomycin with meropenem. We tested for resistance genes and performed typing using PCR and WGS. Thirteen patients received fosfomycin (seven immunosuppressed); they had bloodstream infections (n = 11; 85%), ventilator-associated pneumonia (n = 1; 8%) and surgical site infection (n = 1; 8%), caused by Klebsiella pneumoniae (n = 9), Serratia marcescens (n = 3) and Pseudomonas aeruginosa (n = 1). Overall, eight (62%) patients were cured. Using time-kill assays, synergism between fosfomycin and meropenem occurred in 9 (82%) of 11 isolates. Typing demonstrated that K. pneumoniae were polyclonal. Eight patients (62%) had possible adverse events, but therapy was not discontinued. Fosfomycin may be safe and effective against infections caused by pan-drug-resistant Gram-negative microorganisms with different antimicrobial resistance mechanisms and there seems to be synergism with meropenem.

1 November 2016 in Medicine
Verified
Journal Article
Open access
EMELISA DONALISIO TEIXEIRA MENDES
ELISA DONALISIO TEIXEIRA MENDES
OROtavio T. Ranzani
Otavio T. Ranzani
AMAna Paula Marchi
Ana Paula Marchi
MSMariama Tomaz da Silva
Mariama Tomaz da Silva
JFJosé Ulysses Amigo Filho
José Ulysses Amigo Filho
SCSilvia Figueiredo Costa
Silvia Figueiredo Costa
Health care associated infections (HAIs) are currently among the major challenges to the care of hematopoietic stem cell transplantation (HSCT) patients. The objective of the present study was to evaluate the impact of 2% chlorhexidine (CHG) bathing on the incidence of colonization and infection with vancomycin-resistant Enterococcus (VRE), multidrug-resistant (MDR) gram-negative pathogens, and to evaluate their CHG minimum inhibitory concentration (MIC) after the intervention. A quasi-experimental study with duration of 9 years was conducted. VRE colonization and infection, HAI rates, and MDR gram-negative infection were evaluated by interrupted time series analysis. The antibacterial susceptibility profile and mechanism of resistance to CHG were analyzed in both periods by the agar dilution method in the presence or absence of the efflux pump inhibitor carbonyl cyanide-m-chlorophenyl hydrazone (CCCP) and presence of efflux pumps (qacA/E, qacA, qacE, cepA, AdeA, AdeB, and AdeC) by polymerase chain reaction (PCR). The VRE colonization and infection rates were significantly reduced in the postintervention period (P = 0.001). However, gram-negative MDR rates in the unit increased in the last years of the study. The CHG MICs for VRE increased during the period of exposure to the antiseptic. A higher MIC at baseline period was observed in MDR gram-negative strains. The emergence of a monoclonal Pseudomonas aeruginosa clone was observed in the second period. Concluding, CHG bathing was efficient regarding VRE colonization and infection, whereas no similar results were found with MDR gram-negative bacteria.

1 July 2018 in Journal of Hospital Infection
Verified
Journal Article
Closed access
AMA.P. Marchi
A.P. Marchi
LNL.V. Perdigão Neto
L.V. Perdigão Neto
RMR.C.R. Martins
R.C.R. Martins
CRC.F. Rizek
C.F. Rizek
Carlos Henrique CamargoCarlos Henrique Camargo
Carlos Henrique Camargo
SCS.F. Costa
S.F. Costa

30 November 2018 in Bone Marrow Transplantation
Verified
Journal Article
Closed access
PDF file
HHHermes Higashino
Hermes Higashino
AMAna Paula Marchi
Ana Paula Marchi
RMRoberta Cristina Ruedas Martins
Roberta Cristina Ruedas Martins
MBMarjorie Vieira Batista
Marjorie Vieira Batista
LNLauro Vieira Perdigão Neto
Lauro Vieira Perdigão Neto
SCSilvia Figueiredo Costa
Silvia Figueiredo Costa

17 March 2017 in BMC Microbiology
Verified
Journal Article
Open access
PDF file
JRJuliana Ferraz Rosa
Juliana Ferraz Rosa
CRCamila Fonseca Rizek
Camila Fonseca Rizek
AMAna Paula Marchi
Ana Paula Marchi
TGThaís Guimarães
Thaís Guimarães
LMLourdes Miranda
Lourdes Miranda
SCSilvia F Costa
Silvia F Costa
Carbapenems resistance in Enterobacter spp. has increased in the last decade, few studies, however, described the mechanisms of resistance in this bacterium. This study evaluated clonality and mechanisms of carbapenems resistance in clinical isolates of Enterobacter spp. identified in three hospitals in Brazil (Hospital A, B and C) over 7-year. Antibiotics sensitivity, pulsed-field gel electrophoresis (PFGE), PCR for carbapenemase and efflux pump genes were performed for all carbapenems-resistant isolates. Outer-membrane protein (OMP) was evaluated based on PFGE profile. A total of 130 isolates of Enterobacter spp were analyzed, 44/105 (41, 9%) E. aerogenes and 8/25 (32,0%) E. cloacae were resistant to carbapenems. All isolates were susceptible to fosfomycin, polymyxin B and tigecycline. KPC was present in 88.6% of E. aerogenes and in all E. cloacae resistant to carbapenems. The carbapenems-resistant E. aerogenes identified in hospital A belonged to six clones, however, a predominant clone was identified in this hospital over the study period. There is a predominant clone in Hospital B and Hospital C as well. The mechanisms of resistance to carbapenems differ among subtypes. Most of the isolates co-harbored blaKPC, blaTEM and /or blaCTX associated with decreased or lost of 35–36KDa and or 39 KDa OMP. The efflux pump AcrAB-TolC gene was only identified in carbapenems-resistant E. cloacae. There was a predominant clone in each hospital suggesting that cross-transmission of carbapenems-resistant Enterobacter spp. was frequent. The isolates presented multiple mechanisms of resistance to carbapenems including OMP alteration.

1 September 2016 in Journal of Global Antimicrobial Resistance
Verified
Journal Article
Closed access
GPGladys Villas Boas Do Prado
Gladys Villas Boas Do Prado
AMAna Paula Marchi
Ana Paula Marchi
LMLuisa Zanolli Moreno
Luisa Zanolli Moreno
CRCamila Rizek
Camila Rizek
UAUlisses Amigo
Ulisses Amigo
SCSilvia F. Costa
Silvia F. Costa